ClinicalTrials.govpublic full text
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
multiple myeloma, non-hodgkin lymphoma, b-cell lymphoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 839549
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.